Feasibility Study Incorporating Lung Function Imaging Into Radiation Therapy for Lung Cancer Patients

Study summary

The proposed study is in the field of thoracic radiation oncology where radiation therapy is used to treat lung cancer. The primary objective of the early phase clinical trial will be to evaluate the safety of performing functional avoidance radiation therapy for lung cancer patients using 4D computed tomography (4DCT) ventilation imaging.

Ask AI to explain this study

Start here

Key things to know

Main goalTreatment

This describes the study’s primary purpose.

What is being studiedRadiation therapy

The study team can explain what participation involves.

Who it may be forLung Neoplasms · Lung Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Jul 22, 2021 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?2 U.S. locations

Locations may change over time.

Who runs it?University of Colorado, Denver

Study sponsor

Study overview

What this study is about

Purpose: Treatment
Study type: Interventional
Phase: Not applicable
Sponsor: University of Colorado, Denver
Interventions being studied: Radiation: Radiation therapy

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach

Radiation therapy→

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

1. Diagnosis of pathologically confirmed lung cancer by tumor biopsy and/or fine-need aspiration 2. Lung Cancer patients that will undergo definitive radiation therapy defined as 45-75 Gy as part of standard of care for their disease 3. 18 years of age or older 4. Signed informed consent 5. Planned curative intent chemotherapy, delivered concurrently or sequentially in combination with radiotherapy 6. The patient's 4DCT-ventilation image meets image heterogeneity criteria

Reasons someone may not be able to joinExclusion criteria

1. Patients receiving Stereotactic Body Radiation Therapy 2. Patient receiving palliative radiation therapy (defined as less than 45 Gy)

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

University of Colorado Cancer CenterAurora, Colorado
Beaumont Health SystemRoyal Oak, Michigan

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jul 22, 2021. Always confirm current availability with the study team.

View original record ↗